Home » CorTec Presents New Structure of Advisory Board

CorTec Presents New Structure of Advisory Board

On the way to new personalized therapies for neurological diseases, CorTec is rearranging the structure of its advisory board. A new company advisory board has been created. Board members are Prof. Dr. Klaus Mangold, Dr. Hans Dietl and Bernhard Meder, three experienced advisors who will support the young medical engineering company located in Freiburg, Germany in its future development.

The two managing directors of CorTec, Dr. Jörn Rickert and Dr. Martin Schüttler are delighted about the composition of the two advisory boards which are bolstering the company from now on: ” Prof. Dr. Klaus Mangold‘s international industry expertise, coupled with Bernhard Meder’s entrepreneurial competence and of Dr. Hans Dietl’s profound knowledge of the implant sector is a winning combination for us”, summarizes Dr. Martin Schüttler.  “In addition to this entrepreneurial body, the Scientific and Technical Advisory Board with whom we are discussing the challenges of our product development is a wonderful extension,” adds Dr. Jörn Rickert.

Prof. Dr. Klaus Mangold takes over the chairmanship of the newly formed company advisory board. The Chairman of the Supervisory Board of TUI AG is also a member of supervisory and advisory boards of various international market-listed companies, including Continental AG (Hanover), Ernst & Young (London) and Alstom S.A. (Paris). As a serial entrepreneur, Bernhard Meder has set up several companies in the field of reed technology which he has led to worldwide success within the Meder electronic Group founded by him in 1986. As Chief Technology Officer of Otto Bock HealthCare GmbH, Dr. Hans Dietl has an outstanding experience in the implant business.

The advisory board advises and supervises the management of the company. The Scientific and Technical Advisory Board consists of professional from academia and industry  with technological and application expertise. Prof. Dr. Thomas Stieglitz (Laboratory of Biomedical Microtechnology, University of Freiburg), Prof. Dr. Ulf Ziemann (Medical Director Department of Neurology, University Hospital Tübingen) and Alexander Mayr (Production Manager Med-El) will continue to support the development of CorTec’s Brain Interchange® Technology and their potential applications.

Prof. Dr. Klaus Mangold describes the work in the new advisory board structure as extremely promising: “CorTec is a young company with great potential. As advisory board members, we support the technological development as well as the development of the company itself with the broad range of our expertise. We are looking forward to the growth of the company in the coming years, combined with the extension of its own cleanroom manufacturing facilities.”


Download the Press Release:


Learn more about our Advisory Board


Want to join our team? Check out our vacancies

May 23, 2024

FDA approves Investigational Device Exemption for Early Feasibility Study for rehabilitation of stroke patients using CorTec’s Closed-Loop Brain Interchange implant system.

April 30, 2024

Bernstein-CorTec Award 2024: Call for Thesis Nominations!

March 28, 2024


February 20, 2024

Save the Date – Bernstein Special Seminar on 28th of February

February 1, 2024

Press Release: CorTec ready for next phase with Brain Interchange System

January 26, 2024

CorTec featured in “Open Access Government”: A Step Closer to Enhanced Stroke Rehabilitation

October 18, 2023

Bernstein-CorTec Award 2023

September 8, 2023

Meet us in Boston!